Your session is about to expire
← Back to Search
Virtual Reality Therapy for Gastrointestinal Cancer Pain
Study Summary
This trial will assess the impact of immersive VR on pain and other patient-reported outcomes for people with digestive tract malignancies, as well as differences between skills-based VR therapy and distraction VR therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer type is one of the following: adenocarcinoma, squamous cell, neuroendocrine, or mesenchymal.I don't have seizures, facial injuries, or visual problems that prevent using VR.I can think and understand well enough to follow study instructions.My cancer is in the digestive system and surgery isn't planned.My cancer has spread to my brain.Your doctor expects that you will live for less than 3 months from the time you join the study.I experience significant stomach pain, scoring 5 points above the average on a pain scale.
- Group 1: Virtual Reality Program A
- Group 2: Virtual Reality Program B
- Group 3: Virtual Reality Program C
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment extend to individuals who are 45 years or older?
"This medical study is seeking out individuals aged 18 or higher and below 99 years old."
Is enrollment available for this experiment?
"As per current information posted on clinicaltrials.gov, this research project is still accepting participants. The trial was originally published on October 5th 2021 and has since undergone one revision, occurring August 9th 2022."
Has the FDA acknowledged PICO G2 4k as a certified medical device?
"Though there is preliminary evidence of safety, no clinical data confirms efficacy so our team has ranked PICO G2 4k with a score of 2."
To whom does the eligibility criteria for this trial apply?
"To be accepted into this clinical study, applicants should have a diagnosis of gallbladder cancer and must lie between 18-99 years old. A total of 360 patients need to be enrolled in the trial."
How many people are partaking in this experimental research?
"Affirmative. Per the information hosted on clinicaltrials.gov, this trial is actively accruing patients and was first made available on October 5th 2021. The study has a target of 360 participants that need to be enrolled at a single medical centre before it can begin."
Share this study with friends
Copy Link
Messenger